UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNBR
1801
DELISTED
Sleep Number
SNBR
| $922K | ﹤0.01% |
22,132
-2,698
| -11% | -$85.8K |
|
1802
Innoviva
INVA
$1.48B
| $921K | ﹤0.01% |
65,868
-14,189
| -18% | -$193K |
|
1803
Cactus
WHD
$5.44B
| $914K | ﹤0.01% |
44,297
+8,352
| +23% | +$145K |
|
|
SILK
1804
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $913K | ﹤0.01% |
21,800
+15,300
| +235% | +$587K |
|
1805
Arbor Realty Trust
ABR
$998M
| $913K | ﹤0.01% |
98,771
+37,500
| +61% | +$289K |
|
1806
Theravance Biopharma
TBPH
$877M
| $912K | ﹤0.01% |
43,428
+9,624
| +28% | +$247K |
|
1807
Park National Corp
PRK
$3.67B
| $911K | ﹤0.01% |
12,937
-3,478
| -21% | -$254K |
|
|
CADE
1808
DELISTED
Cadence Bancorporation
CADE
| $907K | ﹤0.01% |
102,403
-38,100
| -27% | -$272K |
|
1809
Myriad Genetics
MYGN
$312M
| $905K | ﹤0.01% |
79,834
-13,943
| -15% | -$198K |
|
|
ATRI
1810
DELISTED
Atrion Corp
ATRI
| $901K | ﹤0.01% |
1,415
-125
| -8% | -$81.7K |
|
|
ADAM
1811
Adamas Trust
ADAM
$883M
| $901K | ﹤0.01% |
86,335
-6,804
| -7% | -$59.7K |
|
1812
OceanFirst Financial
OCFC
$1.91B
| $901K | ﹤0.01% |
51,116
+864
| +2% | +$13.8K |
|
|
NGD
1813
DELISTED
New Gold Inc
NGD
| $901K | ﹤0.01% |
666,945
-8,200
| -1% | -$8.23K |
|
|
LGF.B
1814
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $900K | ﹤0.01% |
131,739
-24,122
| -15% | -$167K |
|
1815
Helios Technologies
HLIO
$2.76B
| $898K | ﹤0.01% |
24,115
-3,880
| -14% | -$132K |
|
1816
Smith & Wesson
SWBI
$637M
| $891K | ﹤0.01% |
53,846
-3,317
| -6% | -$30.8K |
|
|
MIK
1817
DELISTED
Michaels Stores, Inc
MIK
| $890K | ﹤0.01% |
125,930
-2,092
| -2% | -$8.21K |
|
1818
GeoPark
GPRK
$612M
| $881K | ﹤0.01% |
90,015
-13,813
| -13% | -$124K |
|
1819
United Parks & Resorts
PRKS
$2.12B
| $875K | ﹤0.01% |
59,107
+5,088
| +9% | +$75K |
|
1820
Fortuna Silver Mines
FSM
$3.07B
| $868K | ﹤0.01% |
171,410
+102,947
| +150% | +$372K |
|
1821
Standard Motor Products
SMP
$911M
| $868K | ﹤0.01% |
21,058
-546
| -3% | -$22.1K |
|
1822
AZZ Inc
AZZ
$4.54B
| $866K | ﹤0.01% |
25,239
-1,495
| -6% | -$45.7K |
|
1823
TriCo Bancshares
TCBK
$1.83B
| $866K | ﹤0.01% |
28,439
+293
| +1% | +$8.36K |
|
1824
Compugen
CGEN
$228M
| $866K | ﹤0.01% |
+57,650
| New | +$778K |
|
|
BRKL
1825
DELISTED
Brookline Bancorp
BRKL
| $866K | ﹤0.01% |
85,885
+14,009
| +19% | +$140K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.